Oncternal Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Oncternal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.85M, a 7.98% increase year-over-year.
  • Oncternal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.81M, a 3.81% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.5M, a 0.93% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.43M, a 26.5% increase from 2021.
  • Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.88M, a 278% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.5M +$69K +0.93% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $7.43M +$1.56M +26.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $5.88M +$4.32M +278% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.56M +$1.05M +207% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $507K +$327K +182% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-03-12
2018 $180K -$3.14M -94.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $3.32M +$228K +7.38% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $3.09M +$356K +13% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $2.73M -$1.82M -40% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 $4.55M +$685K +17.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
2013 $3.87M +$1.05M +37.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $2.82M -$1.59M -36% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $4.4M -$482K -9.87% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $4.89M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.